Influence of lymphatic endothelial cells on proliferation and invasiveness of esophageal carcinoma cells in vitro and lymphangiogenesis in vivo

Medical Oncology

Volumn 32, Issue 8, 2015, Pages

  Yang, Xu ^a   Zhai, Nana ^b   Sun, Miaomiao ^c   Zhao, Zhihua ^a   Yang, Jianping ^a   Chen, Kuisheng ^a   Zhang, Hongxin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b HUANGHE SCIENCE AND TECHNOLOGY COLLEGE   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

Esophageal carcinoma; Invasiveness; Metastasis; Tumor lymphatic endothelial cells

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; CONDITIONED MEDIUM; TIMP2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROL GROUP; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ESOPHAGUS CARCINOMA; FILTERS AND MEMBRANES; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STAINING; TISSUE TRANSPLANTATION; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CONDITIONED MEDIUM; DRUG EFFECTS; ESOPHAGUS TUMOR; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; ESOPHAGEAL NEOPLASMS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MATRIX METALLOPROTEINASE 9; MICE, NUDE; MICROVESSELS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84938890457     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-015-0662-3     Document Type: Article

References (17)

1. Song J, Su H, Zhou YY, et al. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis. Asian Pac J Cancer Prev. 2013;14(3):1615–21.
2. Zhu M, Zhang N, He S. MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer. FEBS Lett. 2013;14(57):93–6.
3. Zebrowska A, Narbutt J, Sysa-Jedrzejowska A, et al. The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis. Mediat Inflamm. 2005;25(6):373–9.
4. Mellick AS, Blackmore D, Weinstein SR. An assessment of MMP and TIMP gene expression in cell lines and stroma—tumour differences in microdissected breast cancer biopsies. Tumour Biol. 2003;24(5):258–70.
5. Romanowicz L, Galewska Z. Extracellular matrix remodeling of the umbilical cord in pre-eclampsia as a risk factor for fetal hypertension. J Pregnancy. 2011;54(2):69–75.
6. Kawazu T, Nishino T, Obata Y. Production and degradation of extracellular matrix in reversible glomerular lesions in rat model of habu snake venom-induced glomerulonephritis. Med Mol Morphol. 2012;45(4):190–8.
7. Mayer AM, Guzman M, Peksa R, et al. Differential effects of domoic acid and E. coli lipopolysaccharide on tumor necrosis factor-alpha, transforming growth factor-beta1 and matrix metalloproteinase-9 release by rat neonatal microglia: evaluation of the direct activation hypothesis. Mar Drugs. 2007;5(3):113–35.
8. Carvalho RR, Pellizzon CH, Justulin L Jr, et al. Effect of mangiferin on the development of periodontal disease: involvement of lipoxin A4, anti-chemotaxic action in leukocyte rolling. Chem Biol Interact. 2008;179(2):344–50.
9. Bellafiore M, Battaglia G, Bianco A, et al. The involvement of MMP-2 and MMP-9 in heart exercise-related angiogenesis. J Transl Med. 2013;11(1):283–9.
10. Cohen JN, Tewalt EF, Rouhani SJ, et al. Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironment. PLoS One. 2014;9(2):74–87.
11. Luo YM, Wan XH, Jiang DQ, et al. Effects of PPAR-gamma agonist rosiglitazone on MMP-9 and TIMP-1 expression of monocyte-derived macrophages isolated from patients with acute coronary syndrome. Zhonghua Xin Xue Guan Bing Za Zhi. 2009;37(8):739–45.
12. Kara S, Yildirim N, Ozer A, et al. Matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and transforming growth factor beta 1 in the aqueous humor and serum of patients with pseudoexfoliation syndrome. Clin Ophthalmol. 2014;29(8):305–9.
13. Wang CL, Chen ZX, Li ZJ, et al. Effect of TIMP-2, MT1-MMP and MMP-2 expression on the in vitro invasive capacity of acute monocytic leukemia SHI-1 cells. Zhonghua Xue Ye Xue Za Zhi. 2010;31(12):798–803.
14. Groblewska M, Mroczko B, Kozlowski M, et al. Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients. Folia Histochem Cytobiol. 2012;50(4):590–8.
15. Wu TY, Zhang TH, Qu LM, et al. MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression. Int J Clin Exp Pathol. 2013;7(1):56–63.
16. Groblewska M, Siewko M, Mroczko B, et al. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer. Folia Histochem Cytobiol. 2012;50(1):12–9.
17. Teijeira A, Rouzaut A, Melero I, et al. Initial afferent lymphatic vessels controlling outbound leukocyte traffic from skin to lymph nodes. Front Immunol. 2012;21(4):433–6.